Carregant...

Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B

Background: Nucleoside analogues such as lamivudine for chronic hepatitis B have an excellent safety profile while patients are on therapy but reactivation flares occur in 19–50% of patients after stopping therapy, some of whom develop liver decompensation. Aims: To describe and report three cases w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lim, S G, Wai, C T, Rajnakova, A, Kajiji, T, Guan, R
Format: Artigo
Idioma:Inglês
Publicat: Copyright 2002 by Gut 2002
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773395/
https://ncbi.nlm.nih.gov/pubmed/12235087
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!